PolyPid (PYPD) Operating Expenses (2019 - 2026)
PolyPid (PYPD) posted Operating Expenses of $7.3 million for Q1 2026, down 7.88% sequentially from $8.0 million in Q4 2025, and up 0.77% YoY from $7.3 million in Q1 2025.
PolyPid (PYPD) Operating Expenses (2019 - 2026) Analysis & Trends
PolyPid has reported Operating Expenses for 8 years, with the latest figure at $7.3 million in Q1 2026.
- Quarterly Operating Expenses rose 0.77% year-over-year to $7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.0 million (up 9.67% YoY) and the FY2025 annual result came in at $31.0 million, up 14.42% from the prior year.
- Operating Expenses slipped to $7.3 million in Q1 2026 per PYPD's latest filing, from $8.0 million in the prior quarter.
- Over five years, Operating Expenses peaked at $11.2 million in Q1 2022 and troughed at $5.0 million in Q3 2023.
- A 5-year average of $7.2 million and a median of $7.1 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2025: Operating Expenses slumped 51.66% in 2023, then jumped 48.62% in 2025.
- Over 5 years, Operating Expenses stood at $6.3 million in 2022, then fell by 7.28% to $5.8 million in 2023, then surged by 38.18% to $8.0 million in 2024, then slipped by 0.61% to $8.0 million in 2025, then fell by 7.88% to $7.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $7.3 million, $8.0 million, and $7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | PolyPid | 113.30 Mn | 106.53 Mn | - | 7.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.39 Mn |
| Mar 31, 2026 | 7.35 Mn |
| Dec 31, 2025 | 7.97 Mn |
| Sep 30, 2025 | 7.02 Mn |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 7.29 Mn |
| Dec 31, 2024 | 8.02 Mn |
| Sep 30, 2024 | 7.14 Mn |
| Jun 30, 2024 | 5.86 Mn |
| Mar 31, 2024 | 6.07 Mn |
| Dec 31, 2023 | 5.81 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 5.46 Mn |
| Mar 31, 2023 | 5.40 Mn |
| Dec 31, 2022 | 6.26 Mn |
| Sep 30, 2022 | 7.92 Mn |
| Jun 30, 2022 | 10.64 Mn |
| Mar 31, 2022 | 11.18 Mn |
| Dec 31, 2021 | 12.51 Mn |
| Sep 30, 2021 | 9.62 Mn |